Sign In   |   Register
EAS Joint sessions with other Societies
Share |

Educational activities for EAS members are central to EAS' mission - to exchange knowledge on the natural history, causes, treatment and prevention of atherosclerosis-related disease. We also believe that it is important to work together with members of related learned and professional societies - to co-organise with them sessions at Congress, and share and exchange knowledge with a wider audience.

Forthcoming Joint Sessions

March 18-20, Prague, Czech Republic
EAS session at the 4th Annual Congress ESVM&ANGIO2018 Symposia

The Symposia includes a European Atherosclerosis Society session on "Recent advances in atherosclerosis and cardiovascular disease prevention".

Recent advances in atherosclerosis and cardiovascular disease prevention

  • Guidelines and cardiovascular disease prevention: What should an angiologist focus on?
  • New and powerful tools how to substantially improve the risk of our patients (not only) with PAD
  • How to wisely choose appropriate nutraceuticals in cardiovascular disease risk management

To the preliminary programme, including the EAS session.

May 05-08, Lisbon, Portugal
EAS 2018 Congress

During the meeting we will explore the latest top research into the mechanisms, diagnosis and treatment of atherosclerosis and related vascular disease, with workshops organised together with the International Atherosclerosis Society (IAS) and the European Society of Cardiology (ESC).

IAS-EAS Joint session

Genetics, metabolomics and cariovascular risk factors
  • High-resolution lipoprotein phenotypes and cardiovascular outcomes
    Samia Mora, Boston, USA
  • Mining the blood for new cardiometabolic marker
    Robert Gerszten, Boston, USA
  • Genes can protect you from CVD – beyond classical risk factor
    Heribert Schunkert, Munich, Germany
  • Genes can hurt you to develop CVD-beyond classical risk factor
    Stefano Romeo, Gothenburg, Sweden

ESC-EAS Joint Session:

Can we really prevent atherosclerosis?
  • Chairs: Jeroen J. Bax and Lale Tokgozoglu
  • Will aggressively lowering of LDL prevent atherosclerosis?
    Alberico L. Catapano, Milan, Italy
  • Early therapy versus late intervention; what works?
    Diedrick Grobbee, Utrecht, The Netherlands
  • Will inhibiting thrombus formation prevent acute coronary syndromes?
    Stephan Gielen, Leipzig, Germany
  • Reality check: Can we get to goals in guidelines?
    Ulrich Laufs, Leipzig, Germany

June 09-12, 2018, Toronto, Canada
Joint session at the 18th International Symposium on Atherosclerosis

Joint EAS-IAS session, Monday June 11 -

Atherosclerosis: From Plaque Biology to Clinical Practice

11:00 - 13:00

Chairs: Lale Tokgözoğlu, Yuji Matsuzawa

  • Mechanisms of plaque vulnerability the statin era: what has changed?
    Gerard Pasterkamp

  • Mechanisms of coronary inflammation and calcification and implications with cardiovascular event
    Ulf Landmesser

  • Insights of intravascular ultrasound on plaque biology: effects of statins and PCSK9 inhibitors
    Stephen Nicholls

  • Coronary calcification and cardiovascular events: the power of zero
    Khurram Nasir

  • Sex Differences in the Adipokine, Lipid, and Immune Profiles of Men and Women with Severe Carotid Atherosclerosis
    Karina Gasbarrino

  • Carotid plaque is a strong surrogate marker for CAC and subclinical CHD in the general population
    Elias Gudmundsson

Are you attending the Congress, visit us in the EAS booth #306.

To the Congress web >>


August 25-29, Munich, Germany
Joint session at ESC 2018 Munich

Joint EAS-ESC sessions:
Tailoring lipid-lowering therapy: Will one size fit all?
Lipoproteins inflammation and atherosclerosis


EAS booth in the exhibition area.
More information to follow.

 

Page last updated 2018-06-07. 
Please check respective meeting websites for details.

Membership Software Powered by YourMembership  ::  Legal